SCHEMBL4932166

SCHEMBL4932166

CCCNc1cc(C)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.38
NPC1 O15118 1/20 0.38
ABL1 P00519 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RIN1 Q13671 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TRPA1 O75762 1/20 0.37
KDM4E B2RXH2 3/20 0.36
MRGPRX4 Q96LA9 3/20 0.36
PLAU P00749 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717953 0.95 HSD17B10 (0.36) HSD17B10ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4358827 0.92 THRA (0.41) HSD17B10ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4932637 0.91 HSD17B10 (0.40) HSD17B10ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4932449 0.90 HSD17B10 (0.39) HSD17B10ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4932752 0.90 THRB (0.41) MEN1RAB9AKMT2AHPGDNPC1
SCHEMBL4929428 0.87 ALDH1A1 (0.39) HSD17B10ALDH1A1MEN1RAB9AKMT2A
SCHEMBL4931839 0.87 TRPA1 (0.46) ALDH1A1TRPA1MRGPRX4CYP1A2
SCHEMBL4931357 0.87 THRA (0.48) ALDH1A1MEN1RAB9AKMT2AGAA
SCHEMBL5717958 0.86 HSD17B10 (0.36) HSD17B10ALDH1A1MEN1RAB9AKMT2A
SCHEMBL5717763 0.86 HSD17B10 (0.37) HSD17B10ALDH1A1MEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA HSD17B10 1738/4885ALDH1A1 1818/4885MEN1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.